Literature DB >> 10697826

Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder.

D G Dikeos1, G N Papadimitriou, D Avramopoulos, G Karadima, E G Daskalopoulou, D Souery, J Mendlewicz, D Vassilopoulos, C N Stefanis.   

Abstract

Dopamine neurotransmission has been implicated in the pathophysiology of schizophrenia and, more recently, affective disorders. Among the dopamine receptors, D3 can be considered as particularly related to affective disorders due to its neuroanatomical localization in the limbic region of the brain and its relation to the serotoninergic activity of the CNS. The possible involvement of dopamine receptor D3 in unipolar (UP) major depression was investigated by a genetic association study of the D3 receptor gene locus (DRD3) on 36 UP patients and 38 ethnically matched controls. An allelic association of DRD3 (Bal I polymorphism) and UP illness was observed, with the Gly-9 allele (allele '2', 206/98 base-pairs long) being more frequent in patients than in controls (49% vs 29%, P < 0.02). The genotypes containing this allele (1-2 and 2-2) were found in 75% of patients vs 50% of controls (P < 0.03, odds ratio = 3.00, 95% CI = 1.12-8.05). The effect of the genotype remained significant (P < 0.02) after sex and family history were controlled by a multiple linear regression analysis. These results further support the hypothesis that dopaminergic mechanisms may be implicated in the pathogenesis of affective disorder. More specifically, the '2' allele of the dopamine receptor D3 gene seems to be associated with unipolar depression and can be considered as a 'phenotypic modifier' for major psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10697826     DOI: 10.1097/00041444-199912000-00005

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  10 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

Review 2.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

3.  The dopamine D3 receptor gene and posttraumatic stress disorder.

Authors:  Erika J Wolf; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Annemarie F Reardon; Alison Aiello; Sandro Galea; Karestan C Koenen; Monica Uddin; Derek Wildman; Mark W Miller
Journal:  J Trauma Stress       Date:  2014-08

Review 4.  The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.

Authors:  Albert F G Leentjens
Journal:  Drugs       Date:  2011-02-12       Impact factor: 9.546

Review 5.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

Review 6.  Adolescent depression: stress and reward dysfunction.

Authors:  Randy P Auerbach; Roee Admon; Diego A Pizzagalli
Journal:  Harv Rev Psychiatry       Date:  2014 May-Jun       Impact factor: 3.732

7.  Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders.

Authors:  Mesut Yıldız; Mehmet Vural; Mehmet Emin Erdal; Özlem İzci Ay; Şenay Görücü Yılmaz; İbrahim Fatih Karababa; Salih Selek
Journal:  Iran J Reprod Med       Date:  2015-04

8.  Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease.

Authors:  Katherine E McDonell; Nelleke C van Wouwe; Madaline B Harrison; Scott A Wylie; Daniel O Claassen
Journal:  Brain Behav       Date:  2018-06-01       Impact factor: 2.708

9.  The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement.

Authors:  Jonathan Savitz; Colin A Hodgkinson; Chantal Martin-Soelch; Pei-Hong Shen; Joanna Szczepanik; Allison Nugent; Peter Herscovitch; Anthony A Grace; David Goldman; Wayne C Drevets
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 10.  The Role of G-proteins and G-protein Regulating Proteins in Depressive Disorders.

Authors:  Nicolas B Senese; Mark M Rasenick; John R Traynor
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.